Dr. Douglas Orr, MD
Claim this profileMary Crowley Cancer Research
Expert in Solid Tumors
Studies Tumors
17 reported clinical trials
31 drugs studied
About Douglas Orr, MD
Education:
- Received an MD from Vanderbilt University Medical School.
Experience:
- Specializes in medical oncology and hematology.
- Associated with Mary Crowley Cancer Research, focusing on innovative clinical trials.
- Experienced in early phase solid tumor and hematology trials, including first-in-human trials.
Area of expertise
1Solid Tumors
Global LeaderStage IV
NF2 positive
Stage III
2Tumors
Stage IV
Stage III
HPV negative
Affiliated Hospitals
Clinical Trials Douglas Orr, MD is currently running
EU101
for Solid Cancers
Phase 1 (Dose Escalation) of this study will assess the safety, tolerability, dose-limiting toxicity (DLT), and will determine the maximum tolerated dose (MTD) and recommended Phase 2 dose (RP2D) of EU101 in participants with advanced solid tumors. Phase 2 (Dose Expansion) of the study will assess the antitumor effect of EU101 in two indications including colorectal cancer (CRC) and non-small cell lung cancer (NSCLC).
Recruiting1 award Phase 1 & 210 criteria
SIM1811-03
for Cutaneous T-Cell Lymphoma
This is a first in human, open-label, dose escalation and expansion Phase 1 study of SIM1811-03 in adult patients with advanced solid tumors and cutaneous T-cell lymphoma. SIM1811-03 is a first-in-class IgG1-based humanized anti-tumor necrosis factor type 2 receptor (TNFR2) monoclonal antibody for the treatment of malignant tumors.
Recruiting1 award Phase 1
More about Douglas Orr, MD
Clinical Trial Related3 years of experience running clinical trials · Led 17 trials as a Principal Investigator · 14 Active Clinical TrialsTreatments Douglas Orr, MD has experience with
- Pembrolizumab
- ELU001
- EU101
- PEEL-224
- PRO1184
- LCB84
Breakdown of trials Douglas Orr, MD has run
Tumors
Non-Small Cell Lung Cancer
Pancreatic Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Douglas Orr, MD specialize in?
Douglas Orr, MD focuses on Solid Tumors and Tumors. In particular, much of their work with Solid Tumors has involved Stage IV patients, or patients who are NF2 positive.
Is Douglas Orr, MD currently recruiting for clinical trials?
Yes, Douglas Orr, MD is currently recruiting for 14 clinical trials in Dallas Texas. If you're interested in participating, you should apply.
Are there any treatments that Douglas Orr, MD has studied deeply?
Yes, Douglas Orr, MD has studied treatments such as Pembrolizumab, ELU001, EU101.
What is the best way to schedule an appointment with Douglas Orr, MD?
Apply for one of the trials that Douglas Orr, MD is conducting.
What is the office address of Douglas Orr, MD?
The office of Douglas Orr, MD is located at: Mary Crowley Cancer Research, Dallas, Texas 75230 United States. This is the address for their practice at the Mary Crowley Cancer Research.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.